Elsevier

Neuroscience Letters

Volume 291, Issue 3, 22 September 2000, Pages 187-190
Neuroscience Letters

Benzodiazepine modulation of GABAergic responses is intact in the cerebellum of aged F344 rats

https://doi.org/10.1016/S0304-3940(00)01417-8Get rights and content

Abstract

During the aging process there is a decline in the function of many central nervous system receptor systems. In this report we examine the ability of midazolam to potentiate γ-aminobutyric acid (GABA) mediated inhibition recorded from cerebellar Purkinje neurons using extracellular recording methods. We report that when midazolam is applied concurrently with GABA from glass multibarrel electrodes that midazolam potentiates GABA mediated inhibition in 46% of Purkinje neurons in 3-month-old F344 rats, 63% of neurons in 18-month-old F344 rats and 54% of cells in 24-month-old F344 rats. Thus, there is no age related decline in function of this response. In fact, the response to midazolam is significantly increased in 18-month-old rats.

References (23)

Cited by (13)

  • Pharmacotherapy in the ageing patient: The impact of age per se (A review)

    2015, Ageing Research Reviews
    Citation Excerpt :

    Many studies have found increased sensitivity to the effect of benzodiazepines in older people in the absence of any attributable pharmacokinetic change (Kanto et al., 1981; Albrecht et al., 1999), whereas for some benzodiazepines no changes in pharmacodynamic response have been observed (Pomara et al., 1997). The exact mechanism of these pharmacodynamic changes for benzodiazepines are not well established; GABA receptor binding itself is not affected by the ageing process (Ruano et al., 1996; Sundman et al., 1997; Bickford and Breiderick, 2000). Since most of these pharmacodynamic studies have examined older patients only, the altered disease pathophysiology in older patients (compared to younger patients) may be a reason for the observed changes in the pharmacodynamic behaviour of medications (McLean and Le Couteur, 2004).

  • Pharmacodynamics in Older Adults: A Review

    2007, American Journal Geriatric Pharmacotherapy
  • The effect of chronic lorazepam administration in aging mice

    2006, Brain Research
    Citation Excerpt :

    Another group was unable to demonstrate alterations in the pharmacokinetics of intravenous midazolam and oxazepam administration with age despite the age-related differences in sensitivity observed with both drugs (Hovinga et al., 1992; Stijnen et al., 1992). As with human studies, there have also been some investigators who have not found an increased sensitivity to benzodiazepines in aged rodents (Bickford and Breiderick, 2000; Wikinski et al., 2001). Additional studies have addressed receptor interactions of benzodiazepines, which bind at a specific site located on the GABAA receptor.

View all citing articles on Scopus
View full text